SCHEMBL8041559

SCHEMBL8041559

NCCNCCNC(=O)C(F)(F)F

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5B Q9Y2D0 5/20 0.77
CA3 P07451 4/20 0.77
CA5A P35218 4/20 0.77
CA14 Q9ULX7 5/20 0.64
CA12 O43570 4/20 0.64
CA6 P23280 4/20 0.64
CA7 P43166 4/20 0.64
CA9 Q16790 4/20 0.64
CA2 P00918 4/20 0.64
CA4 P22748 3/20 0.64
ALDH1A1 P00352 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
POLB P06746 1/20 0.61
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
EPHX1 P07099 1/20 0.50
LMNA P02545 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
CA1 P00915 1/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10232648 1.00 CA5B (0.77) CA5BCA3CA5ACA14CA12
SCHEMBL1252712 0.89 CA3 (0.86) CA5BCA3CA5ACA14CA12
SCHEMBL10231803 0.89 CA3 (0.86) CA5BCA3CA5ACA14CA12
SCHEMBL67885 0.87 ALDH1A1 (0.65) CA5BCA3CA5ACA14CA12
Hydrochloric Acid SCHEMBL5407882 0.85 ALDH1A1 (0.62) CA5BCA3CA5ACA14CA12
SCHEMBL3149189 0.83 ALDH1A1 (0.74) CA5BCA3CA5ACA14CA12
SCHEMBL3302767 0.82 CA5A (0.81) CA5BCA3CA5ACA14CA12
SCHEMBL11981741 0.82 CA5A (0.81) CA5BCA3CA5ACA14CA12
SCHEMBL13861685 0.82 ALDH1A1 (0.79) CA5BCA3CA5ACA14CA12
SCHEMBL6450550 0.81 CA3 (0.73) CA5BCA3CA5ACA14CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080785-A REACTING A ALKYLNEDI-PRIMARY AMINE COMPOUND WITH A PROTECTIVE GROUP SUCH AS TRIFLUOROACETYL OR BENZYL GROUP REAGENT TO FORM AN INTERMEDIATE, REACTING THE INTERMEDIATE WITH HALOACETIC TERT-BYTYL ESTER TO FORM ESTER GROUPS, DEPROTECTING SCHERING AKTIENGESELLSCHAFT (DE) 2000-06-27 US disclosed
EP-0871608-B1 Monofunctionalised EDTA-, DTPA- and TTHA-Derivatives and their use for the preparation of a diagnoctic or therapeutic medicine SCHERING AG (DE) 2000-04-05 EP disclosed
EP-0871608-A1 NOVEL MONOFUNCTIONALISED EDTA, DTPA AND TTHA DERIVATIVES AND THEIR USE IN MEDICAL DIAGNOSIS AND THERAPY SCHERING AKTIENGESELLSCHAFT (DE) 1998-10-21 EP disclosed
WO-1997025305-A1 NOVEL MONOFUNCTIONALISED EDTA, DTPA AND TTHA DERIVATIVES AND THEIR USE IN MEDICAL DIAGNOSIS AND THERAPY SCHERING AKTIENGESELLSCHAFT (DE) 1997-07-17 WO disclosed